2026. The Nuclear β-Catenin Expression as a Prognostic Indicator and Its Clinicopathologic Correlates in Endometrial Adenocarcinoma: A Retrospective Study from Albayda Medical Center, Libya. Razi Medical Journal. (Jun. 2026), 363–368. DOI:https://doi.org/10.69667/rmj.26229.